# Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

> **NCT01953445** · PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** BKM120

## Key facts

- **NCT ID:** NCT01953445
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study sponsor found the trial to be not viable.
- **Last updated:** 2014-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01953445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01953445, "Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01953445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*